Developments in Huntington's Disease: From Genetics to Therapy
Huntington´s Conference, Reykjavik, Iceland
May 15th marks International Huntington's Disease (HD) Awareness Day. In honor of this occasion, a conference will be held at the Reykjavik University in room M101, starting at 1:30 p.m. and running until 4:50 p.m. The conference welcomes all attendees and will be conducted in English, with live streaming available for those who cannot attend in person.
https://vimeo.com/event/3384081
Registration
This conference will explore the latest research and developments in the field of Huntington's disease. Attendees will learn about the genetic development of the disease in Iceland and the potential for therapeutic interventions. They will gain an understanding of the current state of knowledge regarding Huntington's disease and its associated symptoms. Presentations will include updates on the progress of clinical trials, genetic epidemiology in Iceland, segregation of HTT CAG repeats in extended pedigrees, and the latest developments in gene therapy. Discussions will also focus on new approaches to patient care and the implications of new research for those affected by the disease. All attendees will leave with a better understanding of the complexities of Huntington's disease and its treatment.
AGENDA
|
Conference opening |
Willum Þór Þórsson, Minister of Health |
|
|
Reykjavik University and NeurotechEU |
Bryndís Björk Ásgeirsdóttir PhD, Dean Schoolof Social Sciences, Professor Reykjavik University |
|
|
HD-Association of Iceland |
Sveinn Viðar Guðmundsson PhD, President HD-Association of Iceland, Professor Reykjavik University |
|
|
The epidemiology of Huntington's disease inIceland |
Ólafur Árni Sveinsson MD PhD, Neurologist, Landspitali |
|
|
Segregation of HTT CAG repeats in extendedpedigrees |
Hreinn Stefánsson PhD, Head of CNS division, Decode Iceland |
|
|
Of molecules, models, movement and men |
Jón Jóhannes Jónsson MD PhD, Director Dept. Genetics and Molecular Medicine, Landspitali, Professor University of Iceland |
|
|
Coffee break
|
||
|
Clincial research in HD - is there any treatment on the horizon? |
Astri Arnesen, President European Huntington Association |
|
|
What are the needs of people beingpresymptomatic or at-risk for HD? |
Filipa Julio, Vice President Portuguese HD Association |
|
|
Genetic counseling and Huntington disease
|
Vigdís Stefánsdóttir PhD, Genetic CounsellorLandspítali
|
|
|
Roundtable discussions and Q&A |
María K. Jónsdóttir PhD, ProfessorNeuropsychology, Reykjavik University |
|
|
Conference closing |
|
|
